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Characteristics and risk factors associated
with critical illness in pediatric COVID‑19
Grace Fisler1,2* , Stephanie M. Izard3, Sareen Shah1,2, Deirdre Lewis1,2, Mundeep K. Kainth2,4,
Stefan H. F. Hagmann2,4, Joshua A. Belfer2, Lance M. Feld2, Fiore Mastroianni5, Charlotte L. Kvasnovsky2,6,
Christine A. Capone1,2, James Schneider1,2, Todd Sweberg1,2, Charles Schleien1,2, Matthew D. Taylor1,2 and the
Northwell COVID-19 Research Consortium

Abstract
Background: While much has been reported regarding the clinical course of COVID-19 in children, little is known
regarding factors associated with organ dysfunction in pediatric COVID-19. We describe critical illness in pediatric
patients with active COVID-19 and identify factors associated with PICU admission and organ dysfunction. This is a
retrospective chart review of 77 pediatric patients age 1 day to 21 years admitted to two New York City pediatric hospitals within the Northwell Health system between February 1 and April 24, 2020 with PCR + SARS-CoV-2. Descriptive
statistics were used to describe the hospital course and laboratory results and bivariate comparisons were performed
on variables to determine differences.
Results: Forty-seven patients (61%) were admitted to the general pediatric floor and thirty (39%) to the PICU. The
majority (97%, n = 75) survived to discharge, 1.3% (n = 1) remain admitted, and 1.3% (n = 1) died. Common indications for PICU admission included hypoxia (50%), hemodynamic instability (20%), diabetic ketoacidosis (6.7%), mediastinal mass (6.7%), apnea (6.7%), acute chest syndrome in sickle cell disease (6.7%), and cardiac dysfunction (6.7%).
Of PICU patients, 46.7% experienced any significant organ dysfunction (pSOFA >  = 2) during admission. Patients aged
12 years or greater were more likely to be admitted to a PICU compared to younger patients (p = 0.015). Presence
of an underlying comorbidity was not associated with need for PICU admission (p = 0.227) or organ dysfunction
(p = 0.87). Initial white blood cell count (WBC), platelet count, and ferritin were not associated with need for PICU
admission. Initial C-reactive protein was associated with both need for PICU admission (p = 0.005) and presence of
organ dysfunction (p = 0.001). Initial WBC and presenting thrombocytopenia were associated with organ dysfunction
(p = 0.034 and p = 0.003, respectively).
Conclusions: Age over 12 years and initial CRP were associated with need for PICU admission in COVID-19. Organ
dysfunction was associated with elevated admission CRP, elevated WBC, and thrombocytopenia. These factors may be
useful in determining risk for critical illness and organ dysfunction in pediatric COVID-19.
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Background
The SARS-CoV-2 virus has overwhelmed healthcare systems around the world [1, 2]. Disease presentation varies
from asymptomatic infections identified through contact
tracing to fulminant respiratory failure refractory to conventional therapies. Initial data concluded that children
experienced predominantly mild illness with only a handful requiring ICU admission and mechanical ventilation
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[3–8]. Later data identified serious disease in a small subset of children, but concluded the vast majority experience mild infection [9, 10].
The first study on critically ill children with COVID-19
described 48 patients admitted to 14 pediatric intensive
care units (PICU) in the U.S. Over 80% of patients had
underlying medical conditions and two died [11]. These
data are congruent with another multicenter study that
described a high rate of comorbidities and adolescent
age in pediatric patients requiring PICU admission for
COVID-19 [12]. Need for mechanical ventilation in children with COVID-19 has been associated with elevated
CRP in one single-center study [13].
The clinical course of pediatric COVID-19 has been
described in many studies, however there is a paucity of
literature examining factors that contribute to organ dysfunction in children [14–16]. In this study, we set out to
determine factors associated with PICU admission and
acute organ dysfunction in COVID-19 patients. We compare the characteristics between three groups of pediatric
patients admitted with COVID-19 infection: patients not
requiring PICU care, patients admitted to the PICU with
minimal or no organ dysfunction, and patients admitted
to the PICU with organ dysfunction.

Materials and methods
We conducted a retrospective cohort study of all patients
under 21 years of age (n = 77) admitted with COVID-19
to either of our two hospitals that offer pediatric intensive care from February 1, 2020 through April 24, 2020,
during the height of the pandemic in the New York City
area. Data collection closed on June 20, 2020. The dataset
was the same used in an epidemiology study examining
admitting symptoms, but encompassed a longer study
period and included patients at our second hospital [17].
The study was approved by the Northwell Health System Institutional Review Board (#20-0318-CCMC) and
granted a waiver of informed consent.
Cases were identified by medical record documentation of COVID-19 infection in any patient admitted to
our pediatrics service. Data collected included demographics, indication for admission, BMI, presence of preexisting conditions, hospital outcomes, and PELOD-2
and pSOFA scores [18, 19]. Lab values were collected
within 24 h of admission and included white blood cell
count (WBC), platelet count, C-reactive protein (CRP),
and ferritin. ICU interventions were also recorded and
analyzed. Pediatric acute respiratory distress syndrome
(pARDS) was defined using non-invasive measurements
of oxygenation [20].
Data were collected and managed using REDCap
electronic data capture tools hosted at Northwell
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Health [21, 22]. All analyses were performed using SAS
Studio version 3.8 with a p value < 0.05 considered statistically significant.
We identified several possible factors associated with
ICU admission and organ dysfunction a priori. These
were extrapolated from adult COVID-19 and pediatric
multiorgan dysfunction literature. Factors suspected to
be associated with severe disease included older age,
presence of pre-existing comorbidity, increased BMI,
initial WBC, platelet count, CRP, and ferritin [23–25].
Age was categorized into < 60 days, 60 days
to < 5 years, 5 to < 12 years, or >  = 12 years, based
on sample distribution and clinical relevance. For
inferential analysis, age categories were collapsed
into < 12 years versus >  = 12 years. BMI was converted into BMI percentile for those < 20 years old
[26]. Patients in < 5th percentile were categorized as
underweight, 5–85th as normal weight, 85–95th as
overweight, and > 95th as obese. For patients aged
20–21 years, those with BMI < 18.5 were considered
underweight, 18.5 to 25 as normal weight, 25 to 30 as
overweight, and > 30 as obese[27]. Patients < 2 years
were excluded in BMI categorization. For these analyses, categorized BMI was dichotomized into (1) underweight or normal weight and (2) overweight or obese.
Need for respiratory support was defined by need for
high-flow nasal cannula (HFNC) above 4 L per minute,
non-invasive positive pressure ventilation (NIPPV), or
invasive mechanical ventilation (MV). Patients with
missing data were excluded from individual inferential
analyses. Outcomes of interest included ICU admission
during hospital stay (yes versus no) and organ dysfunction (yes versus no).
All variables were summarized descriptively within
the overall sample and the subgroups of floor only, ICU
admission for organ dysfunction and for other reasons.
The Chi-square or Fisher’s exact test was used for categorical variables of interest such as any significant differences across ICU admission and organ dysfunction
outcomes. The Wilcoxon rank sum test was used for
continuous variables.
The pSOFA score is an adaptation of the adult
sequential organ function assessment (SOFA), a part
of the current adult definition of sepsis [18, 28]. An
increase in SOFA score of >  = 2 is associated with a
mortality of 10% in adult patients [29]. We utilized an
increase in pSOFA score of >  = 2 to define significant
organ dysfunction in pediatric patients. We screened
for baseline organ dysfunction when information was
available and adjusted the pSOFA score to reflect the
increase in pSOFA score from baseline. We also examined the PELOD-2 (Pediatric Logistic Organ Dysfunction) score as a second measure.
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Results
General characteristics of patients admitted for pediatric
COVID‑19 (Table 1)

Seventy-seven patients met the inclusion criteria.
All patients were COVID-19 PCR positive by
nasopharyngeal swab. All included patients had primary
COVID-19 infection and none were diagnosed with
Multisystem Inflammatory Syndrome in Children (MISC) as the data collection period encompassed the time of

the initial, primary outbreak of COVID-19 in the region.
Of 77 patients (mean age = 9.5 years), 71 were admitted
to the tertiary children’s medical center and six to the
satellite hospital. Thirty (39%) were admitted to a PICU
and 47 (61%) to a general inpatient ward. No differences
were noted in gender, race, ethnicity, or general preexisting comorbidities.

Table 1 Demographic data and comorbidities
Total cohort (N = 77)

Floor patients (N = 47)

PICU low acuity
(n = 16)a

PICU organ
dysfunction
(n = 14)b

Demographic data
Age (n, %)
  Age < 60 days

20 (26)

16 (34)

3 (19)

1 (7)

  Age 60 days to < 5 years

10 (13)

6 (13)

2 (13)

2 (14)

  Age 5 years to < 12 years

9 (12)

7 (15)

0

2 (14)

  Age >  = 12 years

38 (49)

18 (38)

11 (69)

9 (64)

Female sex (n, %)

40 (53)

23 (49)

9 (56)

8 (57)

BMI (percentile, n, %)c,d
  Underweight (< 5th percentile)

2 (4)

2 (8)

0

0

  Normal weight (5–85th percentile)

26 (58)

13 (52)

7 (78)

6 (55)

  Overweight (85–95th percentile)

5 (11)

3 (12)

1 (11)

1 (9)

  Obese (> 95th percentile)

12 (27)

7 (28)

1 (11)

4 (36)

Race (n, %)
  Black

22 (29)

10 (21)

7 (44)

5 (38)

  White

15 (19)

12 (26)

3 (19)

0

  Asian

9 (12)

5 (11)

1 (6)

3 (21)

  Multiracial/other

28 (36)

17 (36)

5 (31)

6 (43)

  Unknown

3 (4)

3 (6)

0

0

Ethnicity (n, %)
  Hispanic

18 (23)

9 (19)

3 (19)

6 (43)

  Non-Hispanic

55 (71)

37 (79)

11 (69)

7 (50)

  Unknown

4 (5)

1 (2)

2 (13)

1 (7)

Comorbidities (n, %)

a
b

  Prematurity

7 (9)

6 (13)

1 (6)

0

  Respiratory disease

16

8 (17)

5

3 (21)

  Congenital heart disease

5 (6)

2 (4)

2 (13)

1 (7)

  Diabetes mellitus

5 (6)

2 (4)

2 (13)

1 (7)

  Immunosuppression

9 (12)

6 (13)

2 (13)

1 (7)

  Autoimmune disorder

2 (3)

1 (2)

1 (6)

0

  Bone marrow transplant

2 (3)

1 (2)

0

1 (2)

  Kidney disease

1 (1)

1 (2)

0

0

  Cancer

5 (6)

3 (6)

1 (6)

1 (7)

  Genetic disorder

7 (9)

2 (4)

1 (6)

4 (29)

PICU low acuity defined as pSOFA score < 2
PICU organ dysfunction defined as pSOFA score >  = 2

c

BMI category presented for 45 patients (25 floor, 11 ICU organ days, 9 other). 25 missing under 2 years old, 7 missing older than 2 years

d

BMI category for those 20–21 classified as underweight < 18.5, normal 18.5–25, overweight 25–30, obese > 30
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Characterization of organ dysfunction associated
with pediatric COVID‑19

Of 30 ICU patients, 50% presented with hypoxia and 20%
with hemodynamic instability. Other notable admission
indications are in Table 2. Within ± four hours of PICU
admission, 63.3% experienced documented hypoxia
(defined as SpO2 < 90% on room air) and 10% required
vasoactive medications. Two patients (6.7% of PICU
cohort) required renal replacement therapy. There were
no patients with underlying chronic kidney disease in
the PICU cohorts. Of PICU patients, 46.7% experienced
organ dysfunction (Table 2). Specific organ system dysfunction, defined using pSOFA score >  = 1 for organ system category, showed a predominance of cardiovascular
and respiratory failure (Table 2).

Characterization of respiratory failure (Table 2)

Among patients admitted to the PICU, NIPPV (bilevel
or continuous positive pressure, HFNC) was required
by 30% of patients; 6.7% were managed exclusively with
HFNC.
Among PICU patients, 27% (n = 8) required endotracheal intubation. The average oxygen saturation index
(OSI), a non-invasive measure of lung disease severity,
upon intubation was 14. Median number of ventilatorfree days was 15. One patient required veno-venous
extracorporeal membranous oxygenation (4 days) for
severe pARDS, and one patient was escalated to highfrequency percussive ventilation and eventually died
secondary to refractory hypoventilation with severe
hypercarbia and hypoxemia. This patient was evaluated
for ECMO and deemed not to be a candidate based on

Table 2 PICU admittance and characteristics
Reason(s) for PICU admission n (%)

Total PICU cohort (N = 30)

Hypoxia

15 (50)

Hemodynamic instability

6 (20)

DKA

2 (7)

Cardiac dysfunction

2 (7)

Mediastinal mass

2 (7)

Apnea

2 (7)

Acute chest syndrome in sickle cell disease

2 (7)

Other

6 (20)

Outcomes
Length of ICU stay, days [mean (median, IQR)]a

8.8 (3.6, 2.5–14.7)

ICU discharge (n, %)

29 (97)

Deceased (n, %)

1 (3)

Respiratory failure

Intubated cohort (N = 8)

OSI at intubation [mean (median, IQR)]

14 (15, 5.5–20)

Maximum PEEP [mean (median)]

12 (13.5)

Ventilator-free days [mean (median, IQR)]

14 (15, 13–23)

PICU admission characteristics

Total cohort (N = 30)

PICU low acuity (n = 16)

PICU organ
dysfunction
(n = 14)

pSOFA [mean (median, IQR)]

2.3 (1.0, 1.0–3.0)

0.6 (1.0, 0–1.0)

44 (3.0, 2.0–7.0)

PELOD-2 [mean (median, IQR)]

2.0 (2.0, 0–3.0)

0.6 (0, 0–2.0)

3.6 (3.5, 2.0–6.0)

System failure (n, %)b
Cardiovascular dysfunction

14 (47)

3 (19)

11 (79)

Respiratory dysfunction

9 (30)

0

9 (64)

Hematalogic dysfunction

6 (20)

0

6 (43)

Neurologic dysfunction

5 (17)

0

5 (36)

Hepatic dysfunction

5 (17)

2 (13)

3 (21)

Renal dysfunction

5 (17)

0

5 (36)

a

Among survivors

b

System failure defined as pSOFA >  = 1 for system category(18)
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institutional guidelines due to pre-existing comorbidities, irrespective of COVID-19 status.
Complications, outcomes, and therapies (Table 2)

Two patients experienced secondary infections during
their hospital course (peritonitis and bacterial pneumonia). No concurrent viral infections were documented in
any patients.
For those discharged from the PICU (n = 29), median
PICU length of stay was 3.6 days. At the close of data collection, 98% of the total cohort was discharged home and
one child died (1.3%).
Interventions targeting COVID-19 among PICU
patients included: hydroxychloroquine 63%, azithromycin 37%, corticosteroids 30%, remdesivir 27%, tocilizumab (anti-IL6R) 13%, anakinra (anti-IL1R) 13%, and
intravenous immunoglobulin (IVIg) 10%.
Factors associated with PICU admission and organ
dysfunction (Table 3)

Age ≥ 12 years was associated with the need for PICU
admission (p = 0.015). Presence of any collected
comorbidity was not associated with PICU admission
(p = 0.227).
Median initial CRP value for floor patients was
9.30 mg/L and for PICU patients 54.1 mg/L (n = 37
patients, p = 0.005). Median initial WBC, platelet, and
ferritin value showed no difference between floor and
PICU patients.
Fourteen patients met criteria for organ dysfunction.
Older age, underlying comorbidity, and BMI were not
associated with organ dysfunction. Median initial WBC
was higher in the organ dysfunction cohort (15.7 versus
7.8K/μL, p = 0.034). Median initial platelet count was
lower in the organ dysfunction cohort (149 versus 268K/
μL, p = 0.003); this association remained when analyzed
for non-hematologic organ dysfunction. Median initial ferritin was similar in organ dysfunction patients
(454.6 ng/mL) and non-organ dysfunction patients
(487.1 ng/mL). Median initial CRP was higher in the
organ dysfunction group than non-organ dysfunction
group (109.7 versus 13.9 mg/L, p = 0.001).

Discussion
The incidence of critical illness from COVID-19 and risk
factors for severe disease in pediatrics are not yet well
defined. Multicenter studies have described high rates
of comorbid conditions in hospitalized children with
COVID-19 [11, 12]. We studied 77 children with COVID19 admitted to two of our hospitals over a 7-week period
with the goal of determining clinical characteristics and
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factors associated with PICU admission and acute organ
dysfunction.
In our cohort of pediatric COVID-19, 39% required
intensive care and 18% developed organ dysfunction,
indicating that symptomatic pediatric patients are at risk
of critical illness. The most common indications for PICU
admission were hypoxia and hemodynamic instability.
Our study found that age > 12 years is associated with
PICU admission (p = 0.015) when compared to younger
children, although this association was unadjusted.
Comorbid pulmonary disease and immunocompromised
status have been associated with more severe disease in
pediatric patients with other strains of Coronaviridae
[30]. Presence of any comorbidity and underlying obesity
were not associated with the need for PICU admission or
organ dysfunction. The rate of comorbidity in our PICU
cohort (42.6%) and our organ dysfunction cohort (50%)
were notably lower than two previously published studies
that utilized reports of disease from many different sites
[11, 12]. As all of our subjects are from the same health
system, we may have avoided some testing and reporting
bias that may have affected previous multicenter studies, as all patients were triaged and treated with the same
protocols. Further, our data indicate that healthy children
can suffer severe manifestations of COVID-19 at similar
rates to those with chronic medical conditions. There is
a need for further study regarding the impact of comorbidities on disease severity in pediatric COVID-19 and
regarding the prevalence of symptomatic disease in pediatric populations.
Marked elevations in serum CRP and WBC were noted
in our PICU cohort. Elevations in CRP may be predictive
of mortality in pediatric severe sepsis and septic shock
[24]. Elevated CRP was associated with mortality in an
adult COVID-19 cohort from China and need for MV
in a pediatric COVID-19 cohort [13, 23]. We identified
WBC, platelet count, CRP and ferritin a priori as variables to examine in relation to need for PICU admission
and development of organ dysfunction. PICU admission and organ dysfunction were both associated with
increased CRP on hospital presentation. Elevated WBC
and thrombocytopenia were associated with organ dysfunction in our cohort. Future research to clarify the
predictive value of CRP, WBC, and thrombocytopenia is
warranted.
Multiple targeted therapies were administered to our
cohort of PICU patients. The heterogeneity in treatment
approach highlights the need for randomized controlled
trials to determine the optimal treatment for the varying phenotypes of COVID-19. Further risk stratification
using biomarkers may allow for more efficient trials in
the future that can target patients at risk for more severe
disease.
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Table 3 Outcomes for PICU admission and organ dysfunction
PICU admission
N = 30

No PICU admission
N = 47

>  = 12 years

20 (66.67)

18 (38.30)

< 12 years

10 (33.33)

29 (61.70)

Yes

17 (56.67)

20 (42.55)

No

13 (43.33)

27 (57.45)

Overweight/obese

7 (35.00)

10 (40.00)

Underweight/normal weight

13 (65.00)

15 (60.00)

54.10 (13.90, 161.90)

9.30 (4.00, 33.10)

446.05 (307.35, 809.35)

525.30 (160.20, 1003.00)

7.8 (5.4–17.1)

7.8 (4.9–12.3)

231 (182–206)

267 (200–419)

Organ dysfunction
N = 14

No organ dysfunction
N = 63

>  = 12 years

9 (64.29)

29 (46.03)

< 12 years

5 (35.71)

34 (53.97)

Yes

7 (50.00)

30 (47.62)

No

7 (50.00)

33 (52.38)

Overweight/obese

5 (45.45)

12 (35.29)

Underweight/normal weight

6 (54.55)

22 (64.71)

109.70 (54.25, 218.15)

13.90 (4.50, 46.70)

454.60 (373.70, 1039.00)

487.10 (178.90, 592.40)

15.7 (6.4–18.5)

7.8 (4.8–11.4)

149 (100–280)

268 (203–392)

p value

Outcome: PICU admission
Age

0.0152

Any comorbidity

BMI category (N = 45)a

0.2267

0.7310

Laboratory data
Initial CRP (N = 37)
  Median (IQR)

Initial ferritin (N = 42)
  Median (IQR)

Initial WBC (N = 69)
  Median (IQR)

0.0053
0.8495
0.1455

Initial platelets
  Median (IQR)

0.0612
p value

Outcome: organ dysfunction
Age

0.2166

Any comorbidity

BMI category (N = 45)1

0.8719

0.7224

Laboratory data
Initial CRPc
  Median (IQR)

0.0011

Initial ferritinb
  Median (IQR)
Initial WBC (N = 69)
  Median (IQR)

0.2125
0.0341

Initial platelets
  Median (IQR)

0.0025

Organ dysfunction defined as pSOFA >  = 2, No organ dysfunction included floor patients and ICU patients with pSOFA < 2
a

b
c

Patients < 2 years old excluded (n = 25) and n = 7 missing >  = 2 years old
Ferritin collected for 42 patients

CRP collected for 37 patients

Limitations of our study include its retrospective
design and relatively small sample size due to this disease’s emerging nature. Multivariable analysis was not

possible due to limited sample size and missing data.
Comparisons herein are intended to develop hypotheses
for future testing. Increasing sample size could allow for
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further definition of risk factors associated with severe
disease and organ dysfunction and allow for refinement
of predictive factors of severe disease. Seven factors were
identified a priori and to maintain appropriate power and
study design; additional laboratory differences could not
be evaluated for statistical significance between groups.
Other statistical comparisons between groups of patients
could be an area of future research.
There were missing lab values, more prominently in the
general floor cohort with a shorter LOS and lower disease severity. This skew in missing data is typical of retrospective studies, given healthier patients tend to have less
clinical indication for laboratory studies. Despite this, the
data suggests an association between elevations in the
inflammatory markers discussed and presence of organ
dysfunction. CRP, WBC, and thrombocytopenia may be
useful tools in predicting patients who will develop organ
dysfunction and is a vital area of future research. As the
COVID-19 pandemic has overwhelmed healthcare systems, early markers of organ dysfunction could assist in
triage decisions. Future studies will be able to include a
larger cohort of patients and allow for refined study of
the clinical characteristics of severe pediatric COVID-19.

Conclusions
COVID-19 can cause severe, life-threatening disease
in children. Older children are more likely to require
PICU admission. Our cohort did not find an association between underlying comorbidity and critical illness or organ dysfunction. CRP, WBC, and platelet
count may be useful markers of organ dysfunction, and
further study is needed.
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